The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial

被引:3
|
作者
Liem, Sophie I. E. [1 ]
Hoekstra, Eva M. [1 ]
Bonte-Mineur, Femke [2 ]
Checa, Cesar Magro [3 ]
Schouffoer, Anne [4 ]
Allaart, Cornelia F. [1 ]
Huizinga, Tom W. J. [1 ]
Bergstra, Sytske Anne [1 ]
de Vries-Bouwstra, Jeska K. [1 ]
机构
[1] Leiden Univ, Dept Rheumatol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands
[2] Maasstad Ziekenhuis, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[3] Zuyderland Med Ctr, Dept Rheumatol, Heerlen, Netherlands
[4] Haga Ziekenhuis, Dept Rheumatol, The Hague, Netherlands
关键词
SSc; scleroderma; RP; silver fibre gloves; crossover trial; MINIMALLY IMPORTANT DIFFERENCE; QUALITY-OF-LIFE; SCLERODERMA; MANAGEMENT;
D O I
10.1093/rheumatology/keac243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Silver fibre gloves transport heat from the palm to the fingers, possibly reducing the burden of RP in SSc patients. We aim to evaluate the clinical efficiency of this intervention. Methods. A multicentre, double-blind, randomized trial was performed, accounting for interindividual differences and external factors using a crossover design. Patients were randomized in two groups: group 1 wore 8% silver fibre gloves in period 1 and normal gloves in period 2 and group 2 vice versa. Each period lasted 6 weeks. The primary outcome was the Raynaud Condition Score (RCS) over time (minimal clinical important difference 1.4), assessed three times per week using an online questionnaire. Secondary outcomes included vascular complications and Scleroderma-Health Assessment Questionnaire (SHAQ). Outcomes were evaluated before unblinding using linear mixed models. Results. A total of 85 SSc patients were included, with 76 completing the study. The mean RCS during 2 weeks before the study (i.e. without gloves) was 6.4 (s.D. 1.6). Both with silver fibre gloves and normal gloves the mean RCS decreased to 3.9 (s.D. 2.3) with a similar course over time. There was no difference in mean RCS over time between the type of gloves [beta=0.067 (95% CI -0.006, 0.19)]. Of secondary outcomes, total SHAQ [beta=0.036 (95% CI 0.026, 0.046)] was slightly higher with silver fibre gloves, which is clinically irrelevant. Three patients developed new digital ulcers with normal gloves vs one patient with silver fibre gloves [odds ratio 3.2 (95% CI 0.32, 31.1)]. Conclusions. Wearing gloves in SSc patients clearly decreases the RP burden. Our results do not support the hypothesis that increased heat transport of 8% silver fibre gloves is associated with less disease burden as measured in this study by the RCS compared with normal gloves.
引用
收藏
页码:SI74 / SI81
页数:8
相关论文
共 50 条
  • [21] CONTROLLED DOUBLE-BLIND TRIAL OF NISOLDIPINE IN THE TREATMENT OF IDIOPATHIC RAYNAUD PHENOMENON
    GJORUP, T
    HARTLING, OJ
    KELBAEK, H
    NIELSEN, SL
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) : 387 - 389
  • [22] Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial
    Oskarsson, Bjorn
    Moore, Dan
    Mozaffar, Tahseen
    Ravits, John
    Wiedau-Pazos, Martina
    Parziale, Nicholas
    Joyce, Nanette C.
    Mandeville, Ross
    Goyal, Namita
    Cudkowicz, Merit E.
    Weiss, Michael
    Miller, Robert G.
    McDonald, Craig M.
    MUSCLE & NERVE, 2018, 58 (01) : 42 - 48
  • [23] A randomized, double-blind, crossover trial of modafinil on mood
    Taneja, Indu
    Haman, Kirsten
    Shelton, Richard C.
    Robertson, David
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (01) : 76 - 79
  • [24] A DOUBLE-BLIND, RANDOMIZED, CROSSOVER TRIAL OF PEMOLINE IN FATIGUE ASSOCIATED WITH MULTIPLE-SCLEROSIS
    WEINSHENKER, BG
    PENMAN, M
    BASS, B
    EBERS, GC
    RICE, GPA
    NEUROLOGY, 1992, 42 (08) : 1468 - 1471
  • [25] A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
    Knobler, RM
    French, LE
    Kim, Y
    Bisaccia, E
    Graninger, W
    Nahavandi, H
    Strobl, FJ
    Keystone, E
    Mehlmauer, M
    Rook, AH
    Braverman, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (05) : 793 - 799
  • [26] Audiovestibular Manifestations in Patients with Primary Raynaud's Phenomenon and Raynaud's Phenomenon Secondary to Systemic Sclerosis
    Carlos Amor-Dorado, Juan
    Martin-Sanz, Eduardo
    Franco-Gutierrez, Virginia
    Urruticoechea-Arana, Ana
    Garcia-Arumi, Ana M.
    Racines-Alava, Erwin
    Aleman-Lopez, Oscar
    Simeon-Aznar, Carmen P.
    Gonzalez-Gay, Miguel A.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [27] Desmopressin in the management of nocturia in patients with multiple sclerosis - A double-blind, crossover trial
    Valiquette, G
    Herbert, J
    MeadeDAlisera, P
    ARCHIVES OF NEUROLOGY, 1996, 53 (12) : 1270 - 1275
  • [28] PROLONGED EFFECT OF CGRP IN RAYNAUD PATIENTS - A DOUBLE-BLIND RANDOMIZED COMPARISON WITH PROSTACYCLIN
    SHAWKET, S
    DICKERSON, C
    HAZLEMAN, B
    BROWN, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (02) : 209 - 213
  • [29] The effect of fampridine SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS
    Morrow, S. A.
    Rosehart, H.
    Johnson, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 807 - 807
  • [30] Efficacy and safety of botulinum toxin B injection for Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis: Single-blind, randomized trial
    Motegi, S.
    Perera, B.
    Sekiguchi, A.
    Fujiwara, C.
    Date, Y.
    Nakamura, T.
    Ishikawa, O.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S197 - S197